Healthcare provider profile · identity verified

Charles R. Griffith, M.D.

Allopathic & Osteopathic Physicians|Family Medicine · COLUMBIA, MS · NPI 1205891975

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Charles R. Griffith, M.D. received $16.92 in general payments during 2025 across 1 reported records.

ABBVIE INC. accounted for 100.0% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 2 associated products.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 196 claims for Linzess by this doctor in 2024.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported VRAYLAR as an associated drug or biological on 377741 records involving 62704 distinct recipient NPIs. Public Medicare Part D data also shows 31 claims for Vraylar by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$16.92

1 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
ABBVIE INC.	Unresolved — no canonical attribution shown	$16.92	100.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$16.92	1

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
QULIPTA Normalized: qulipta	Drug	ABBVIE INC.	$16.92	1	2025
Source payment records 2025-08-06 · ABBVIE INC. · $16.92 · Open Payments source
UBRELVY Normalized: ubrelvy	Drug	ABBVIE INC.	$16.92	1	2025
Source payment records 2025-08-06 · ABBVIE INC. · $16.92 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	LINZESS open payments reported associated product	CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608	Linzess · 2024 Exact normalized brand match · 1 Part D row	196	29
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	VRAYLAR open payments reported associated product	CMS Open Payments — General Payments 377741 supporting records · 62704 recipient NPIs · example record 1201352550	Vraylar · 2024 Exact normalized brand match · 1 Part D row	31	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1306	174
Gabapentin	Gabapentin	1187	153
Furosemide	Furosemide	1015	147
Amlodipine Besylate	Amlodipine Besylate	987	154
Famotidine	Famotidine	974	109
Trazodone Hcl	Trazodone Hcl	782	153
Potassium Chloride	Potassium Chloride	779	122
Pantoprazole Sodium	Pantoprazole Sodium	776	120
Donepezil Hcl	Donepezil Hcl	774	79
Sertraline Hcl	Sertraline Hcl	765	98
Levothyroxine Sodium	Levothyroxine Sodium	740	88
Memantine Hcl	Memantine Hcl	714	90
Eliquis	Apixaban	644	81
Mirtazapine	Mirtazapine	626	93
Duloxetine Hcl	Duloxetine Hcl	594	80
Tamsulosin Hcl	Tamsulosin Hcl	574	78
Losartan Potassium	Losartan Potassium	510	74
Carvedilol	Carvedilol	470	67
Metoprolol Succinate	Metoprolol Succinate	461	83
Buspirone Hcl	Buspirone Hcl	432	56
Metformin Hcl	Metformin Hcl	405	43
Lisinopril	Lisinopril	377	54
Myrbetriq	Mirabegron	361	28
Clopidogrel	Clopidogrel Bisulfate	341	56
Rosuvastatin Calcium	Rosuvastatin Calcium	325	43
Omeprazole	Omeprazole	301	40
Xarelto	Rivaroxaban	299	23
Metoprolol Tartrate	Metoprolol Tartrate	274	66
Escitalopram Oxalate	Escitalopram Oxalate	251	33
Levetiracetam	Levetiracetam	249	29
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	248	106
Sucralfate	Sucralfate	222	37
Jardiance	Empagliflozin	221	23
Torsemide	Torsemide	212	53
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	207	110
Baclofen	Baclofen	201	24
Linzess	Linaclotide	196	29
Allopurinol	Allopurinol	195	26
Divalproex Sodium	Divalproex Sodium	194	23
Citalopram Hbr	Citalopram Hydrobromide	189	18
Metformin Hcl Er	Metformin Hcl	181	26
Olanzapine	Olanzapine	174	16
Fluoxetine Hcl	Fluoxetine Hcl	170	16
Quetiapine Fumarate	Quetiapine Fumarate	167	28
Amiodarone Hcl	Amiodarone Hcl	155	57
Finasteride	Finasteride	151	17
Hydrochlorothiazide	Hydrochlorothiazide	151	24
Januvia	Sitagliptin Phosphate	147	13
Ropinirole Hcl	Ropinirole Hcl	144	18
Fluticasone Propionate	Fluticasone Propionate	143	48
Nortriptyline Hcl	Nortriptyline Hcl	142	26
Simvastatin	Simvastatin	142	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	134	21
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	131	49
Movantik	Naloxegol Oxalate	131	suppressed
Tramadol Hcl	Tramadol Hcl	131	49
Ondansetron Hcl	Ondansetron Hcl	116	44
Hydralazine Hcl	Hydralazine Hcl	112	21
Ezetimibe	Ezetimibe	109	13
Montelukast Sodium	Montelukast Sodium	107	16
Topiramate	Topiramate	107	suppressed
Metolazone	Metolazone	105	20
Lorazepam	Lorazepam	103	20
Cefdinir	Cefdinir	101	77
Latanoprost	Latanoprost	96	22
Pravastatin Sodium	Pravastatin Sodium	96	13
Venlafaxine Hcl Er	Venlafaxine Hcl	96	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	87	suppressed
Nystatin	Nystatin	85	54
Oxybutynin Chloride	Oxybutynin Chloride	83	12
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	82	60
Risperidone	Risperidone	78	suppressed
Azelastine Hcl	Azelastine Hcl	77	27
Aripiprazole	Aripiprazole	76	11
Meloxicam	Meloxicam	75	27
Doxepin Hcl	Doxepin Hcl	73	11
Tresiba Flextouch U-100	Insulin Degludec	72	suppressed
Primidone	Primidone	69	suppressed
Rexulti	Brexpiprazole	69	suppressed
Fluconazole	Fluconazole	66	37
Spironolactone	Spironolactone	64	15
Solifenacin Succinate	Solifenacin Succinate	63	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	62	suppressed
Tizanidine Hcl	Tizanidine Hcl	62	26
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	61	suppressed
Prednisone	Prednisone	61	31
Paroxetine Hcl	Paroxetine Hcl	60	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	59	27
Doxycycline Monohydrate	Doxycycline Monohydrate	59	44
Benztropine Mesylate	Benztropine Mesylate	58	suppressed
Carbamazepine	Carbamazepine	58	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	58	16
Lacosamide	Lacosamide	58	suppressed
Lamotrigine	Lamotrigine	55	suppressed
Methenamine Hippurate	Methenamine Hippurate	55	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	55	13
Carbidopa-Levodopa	Carbidopa/Levodopa	54	suppressed
Oxycodone Hcl	Oxycodone Hcl	53	51
Clonazepam	Clonazepam	52	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	52	22
Entresto	Sacubitril/Valsartan	52	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	51	suppressed
Trintellix	Vortioxetine Hydrobromide	50	suppressed
Atenolol	Atenolol	49	suppressed
Bethanechol Chloride	Bethanechol Chloride	49	suppressed
Brilinta	Ticagrelor	47	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	47	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	47	14
Levofloxacin	Levofloxacin	47	37
Ondansetron Odt	Ondansetron	46	24
Fenofibrate	Fenofibrate	44	suppressed
Novolog Flexpen	Insulin Aspart	44	15
Benazepril Hcl	Benazepril Hcl	43	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	43	38
Labetalol Hcl	Labetalol Hcl	43	suppressed
Farxiga	Dapagliflozin Propanediol	42	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	42	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	41	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	41	suppressed
Rivastigmine	Rivastigmine	41	15
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	40	suppressed
Roflumilast	Roflumilast	40	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	39	33
Doxazosin Mesylate	Doxazosin Mesylate	39	suppressed
Nifedipine Er	Nifedipine	39	suppressed
Ranolazine Er	Ranolazine	39	suppressed
Gemtesa	Vibegron	38	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	38	31
Nuedexta	Dextromethorphan Hbr/Quinidine	38	suppressed
Fluorometholone	Fluorometholone	37	suppressed
Calcitriol	Calcitriol	36	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	36	suppressed
Alendronate Sodium	Alendronate Sodium	35	suppressed
Novolog	Insulin Aspart	35	13
Valproic Acid	Valproic Acid (As Sodium Salt)	35	suppressed
Incruse Ellipta	Umeclidinium Bromide	34	suppressed
Lactulose	Lactulose	34	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	34	suppressed
Estradiol	Estradiol	33	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	11
Phenytoin Sodium Extended	Phenytoin Sodium Extended	33	suppressed
Valsartan	Valsartan	33	suppressed
Anastrozole	Anastrozole	32	suppressed
Levemir Flexpen	Insulin Detemir	32	12
Megestrol Acetate	Megestrol Acetate	32	suppressed
Sotalol	Sotalol Hcl	32	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	31	30
Vraylar	Cariprazine Hcl	31	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	30	suppressed
Diclofenac Sodium	Diclofenac Sodium	30	24
Fiasp	Insulin Aspart (Niacinamide)	30	suppressed
Ibuprofen	Ibuprofen	30	suppressed
Pregabalin	Pregabalin	30	20
Lovastatin	Lovastatin	29	suppressed
Mupirocin	Mupirocin	29	13
Xifaxan	Rifaximin	29	suppressed
Bupropion Xl	Bupropion Hcl	28	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	28	suppressed
Midodrine Hcl	Midodrine Hcl	28	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	28	suppressed
Budesonide	Budesonide	26	suppressed
Insulin Lispro	Insulin Lispro	26	11
Isosorbide Mononitrate	Isosorbide Mononitrate	26	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	26	suppressed
Promethazine Hcl	Promethazine Hcl	26	suppressed
Galantamine Er	Galantamine Hbr	25	suppressed
Irbesartan	Irbesartan	25	suppressed
Phenytoin	Phenytoin	25	suppressed
Tradjenta	Linagliptin	25	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	25	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	24	suppressed
Hydrocortisone	Hydrocortisone	24	suppressed
Nystop	Nystatin	24	17
Celecoxib	Celecoxib	23	suppressed
Insulin Aspart	Insulin Aspart	23	12
Memantine Hcl Er	Memantine Hcl	23	suppressed
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Alprazolam	Alprazolam	22	12
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	22	suppressed
Trimethoprim	Trimethoprim	22	suppressed
Zubsolv	Buprenorphine Hcl/Naloxone Hcl	22	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Carbamazepine Er	Carbamazepine	21	suppressed
Nuplazid	Pimavanserin Tartrate	21	suppressed
Symbicort	Budesonide/Formoterol Fumarate	21	suppressed
Azithromycin	Azithromycin	20	17
Buprenorphine Hcl	Buprenorphine Hcl	20	suppressed
Cyclosporine	Cyclosporine	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Haloperidol	Haloperidol	20	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	19	suppressed
Colestipol Hcl	Colestipol Hcl	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	suppressed
Novolog Mix 70-30	Insulin Aspart Prot/Insuln Asp	19	suppressed
Suboxone	Buprenorphine Hcl/Naloxone Hcl	19	suppressed
Cephalexin	Cephalexin	18	16
Fentanyl	Fentanyl	18	suppressed
Humalog	Insulin Lispro	18	suppressed
Rivastigmine	Rivastigmine Tartrate	18	suppressed
Cholestyramine	Cholestyramine (With Sugar)	17	suppressed
Clindamycin Hcl	Clindamycin Hcl	17	12
Dexamethasone	Dexamethasone	17	12
Ertapenem	Ertapenem Sodium	17	13
Hydroxyurea	Hydroxyurea	17	suppressed
Lidocaine Hcl	Lidocaine Hcl/Pf	17	15
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Timolol Maleate	Timolol Maleate	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	14
Dorzolamide Hcl	Dorzolamide Hcl	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Lagevrio (Eua)	Molnupiravir	16	16
Methotrexate	Methotrexate Sodium	16	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	16	suppressed
Zonisamide	Zonisamide	16	suppressed
Erythromycin	Erythromycin Base	15	suppressed
Glipizide	Glipizide	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	14	suppressed
Diltiazem Hcl	Diltiazem Hcl	14	suppressed
Divalproex Sodium Er	Divalproex Sodium	14	suppressed
Glycopyrrolate	Glycopyrrolate	14	suppressed
Levemir	Insulin Detemir	14	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	14	suppressed
Nitroglycerin	Nitroglycerin	14	14
Ofloxacin	Ofloxacin	14	12
Ozempic	Semaglutide	14	suppressed
Telmisartan	Telmisartan	14	suppressed
Teriflunomide	Teriflunomide	14	suppressed
Albuterol Sulfate	Albuterol Sulfate	13	suppressed
Eszopiclone	Eszopiclone	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Letrozole	Letrozole	13	suppressed
Methimazole	Methimazole	13	suppressed
Prednisolone Acetate	Prednisolone Acetate	13	suppressed
Propafenone Hcl	Propafenone Hcl	13	suppressed
Trospium Chloride	Trospium Chloride	13	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Cefuroxime	Cefuroxime Axetil	12	suppressed
Cilostazol	Cilostazol	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Lubiprostone	Lubiprostone	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	12	suppressed
Oxcarbazepine	Oxcarbazepine	12	suppressed
Restasis	Cyclosporine	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	11	suppressed
Ceftriaxone	Ceftriaxone Sodium	11	suppressed
Colchicine	Colchicine	11	suppressed
Phenobarbital	Phenobarbital	11	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$16.92 · 1 records	ABBVIE INC.	QULIPTA, UBRELVY	2	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error